Drugging the addict: non‐oncogene addiction as a target for cancer therapy
2016 · EMBO Reports · 153 citations
https://doi.org/10.15252/embr.201643030
R
Remco Nagel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
5.8K
Citations
21
h-index
24
i10-index
Remco Nagel is an academic researcher from The Netherlands Cancer Institute. The author has contributed to research in topics: RNA modifications and cancer & FOXO transcription factor regulation & MicroRNA in disease regulation. The author has an h-index of 21, co-authored 100 publications.
Papers by this author
worksAdoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
2025 · Immunity · 7 citations
https://doi.org/10.1016/j.immuni.2024.12.004
Additional file 3 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13668213
Additional file 7 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13668225
Additional file 4 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13668216
Additional file 8 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13668228
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat